Business Description
Nanjing Vazyme Biotech Co Ltd
ISIN : CNE100004ZK3
Share Class Description:
SHSE:688105: Class ACompare
Compare
Traded in other countries / regions
688105.China IPO Date
2021-11-15Description
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.81 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -97.48 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.55 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.5 | |||||
3-Year EBITDA Growth Rate | -58.5 | |||||
3-Year Book Growth Rate | 39.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.77 | |||||
9-Day RSI | 51.84 | |||||
14-Day RSI | 46.66 | |||||
6-1 Month Momentum % | -26.28 | |||||
12-1 Month Momentum % | -27.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.27 | |||||
Quick Ratio | 2.97 | |||||
Cash Ratio | 2.58 | |||||
Days Inventory | 387.09 | |||||
Days Sales Outstanding | 104.21 | |||||
Days Payable | 170.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.5 | |||||
Dividend Payout Ratio | 19.53 | |||||
Forward Dividend Yield % | 0.5 | |||||
5-Year Yield-on-Cost % | 0.5 | |||||
3-Year Average Share Buyback Ratio | -3.6 | |||||
Shareholder Yield % | -7.87 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.59 | |||||
Operating Margin % | -1.34 | |||||
Net Margin % | -1.18 | |||||
FCF Margin % | 0.97 | |||||
ROE % | -0.37 | |||||
ROA % | -0.26 | |||||
ROIC % | -0.21 | |||||
ROC (Joel Greenblatt) % | -0.91 | |||||
ROCE % | -0.26 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 313.28 | |||||
PS Ratio | 6.48 | |||||
PB Ratio | 2.01 | |||||
Price-to-Tangible-Book | 2.13 | |||||
Price-to-Free-Cash-Flow | 169.92 | |||||
Price-to-Operating-Cash-Flow | 39.16 | |||||
EV-to-EBIT | -545.69 | |||||
EV-to-EBITDA | -545.69 | |||||
EV-to-Revenue | 4.71 | |||||
EV-to-FCF | 498.34 | |||||
Price-to-Graham-Number | 5.45 | |||||
Price-to-Net-Current-Asset-Value | 3.28 | |||||
Price-to-Net-Cash | 4.93 | |||||
Earnings Yield (Greenblatt) % | -0.18 | |||||
FCF Yield % | 0.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Vazyme Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,285.365 | ||
EPS (TTM) (Â¥) | -0.04 | ||
Beta | 0 | ||
Volatility % | 55.21 | ||
14-Day RSI | 46.66 | ||
14-Day ATR (Â¥) | 0.876194 | ||
20-Day SMA (Â¥) | 19.754 | ||
12-1 Month Momentum % | -27.95 | ||
52-Week Range (Â¥) | 17.58 - 41.49 | ||
Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanjing Vazyme Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanjing Vazyme Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Nanjing Vazyme Biotech Co Ltd Frequently Asked Questions
What is Nanjing Vazyme Biotech Co Ltd(SHSE:688105)'s stock price today?
The current price of SHSE:688105 is ¥20.05. The 52 week high of SHSE:688105 is ¥41.49 and 52 week low is ¥17.58.
When is next earnings date of Nanjing Vazyme Biotech Co Ltd(SHSE:688105)?
The next earnings date of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is .
Does Nanjing Vazyme Biotech Co Ltd(SHSE:688105) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is 0.5% (As of Today), Highest Dividend Payout Ratio of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) was 19.53. The lowest was 0.2. And the median was 0.2. The  Forward Dividend Yield % of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is 0.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |